Trial OKed for Rare Disease Gene Therapy
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of […]
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of […]
The FDA has recently cleared an Investigational New Drug (IND) application for FBX-101, allowing it to move into a […]
Read More… from Forge Biologics Cleared for Clinical Trial of FBX-101, a Krabbe Disease Treatment
We’re pleased to share that the United Leukodystrophy Foundation has shared our press release, marking yet another avenue of informing […]
Read More… from FDA Clearance of Investigational New Drug for Patients with Krabbe Disease
Ohio-based startup Forge Biologics closed a $40 million Series A financing roundthat will be used to expand manufacturing capabilities and support […]
Ohio-based startup Forge Biologics closed a $40 million Series A financing roundthat will be used to expand manufacturing capabilities and support […]
Read More… from Forge Biologics Launches with $40 Million to Manufacture and Develop Gene Therapies
Forge Biologics, a viral vector gene therapy manufacturing and development company with a platform to develop proprietary gene therapy products, […]
Read More… from Forge Biologics Launches with $40 Million to Manufacture and Develop Gene Therapies
Forge Biologics, a viral vector gene therapy manufacturing and development company with a platform to develop proprietary gene therapy products, […]
A gene therapy startup in Grove City has raised $40 million in venture capital to both bring biotech to market […]
Read More… from Gene therapy company raises $40M to launch in Central Ohio
A gene therapy startup in Grove City has raised $40 million in venture capital to both bring biotech to market […]